Conversely, IL-17 has also been reported to enhance the recruitment of anti-tumor immune cells within tumor tissues, consequently elevating IFN-γ levels within the tumor microenvironment, which plays a role in inhibiting tumor progression [206]. The gene discussed is IL17A; the disease is neoplasm.